Longeveron Inc - Ordinary Shares - Class A

-0.20 (-4.59%)
7:47:03 PM EDT: $4.04 -0.12 (-2.89%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)83.42M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.4 Million
Adjusted EPS-$0.20
See more estimates
10-Day MA$3.98
50-Day MA$3.61
200-Day MA$5.49
See more pivots

Longeveron Inc - Ordinary Shares - Class A Stock, NASDAQ:LGVN

Life Science & Technology Park, 1951 NW 7th Avenue, Miami, Florida 33136
United States of America
Phone: +1.305.909.0840
Number of Employees: 18


Longeveron, Inc. is a clinical stage biotechnology company. It engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffers on October 9, 2014 and is headquartered in Miami, FL.